Sign in

CIK 0001764013 · Large accelerated filer

Immunovant, Inc.

Sign in to watch
Ticker
IMVT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Mar 31
Incorporated
DE
Entity type
operating
EIN
832771572
Phone
917-410-3120
Business address
1000 PARK FORTY PLAZA, DURHAM, NC, 27713
Former names
Health Sciences Acquisitions Corp
  1. 4 Grant or award Chief Technology Officer acquired 66,937 shares (grant or award)
  2. 4 Grant or award Chief Legal Officer acquired 41,343 shares (grant or award)
  3. 4 Grant or award Chief Executive Officer acquired 232,252 shares (grant or award)
  4. 4 Grant or award Chief Financial Officer acquired 64,968 shares (grant or award)
  5. 4 Open-market sale Chief Executive Officer sold 14,229 shares at an average $24.10 ($342,854)
  6. 4 Open-market sale Chief Legal Officer sold 2,877 shares at $24.97 ($71,839)
  7. 4 Open-market sale Chief Operating Officer sold 3,238 shares at an average $27.85 ($90,184)
  8. 4 Open-market sale Chief Technology Officer sold 1,977 shares at $26.03 ($51,461)
  9. 4 Open-market sale Chief Technology Officer sold 1,203 shares at an average $26.53 ($31,914)
  10. 4 Open-market sale Chief Legal Officer sold 10,813 shares at an average $26.91 ($290,943)
  11. 4 Open-market buy Director bought 16,666,666 shares at $21.00 ($349,999,986)
  12. 4 Planned sale Director sold 22,249 shares at an average $23.25 ($517,189)
  13. 4 Planned sale Director sold 15,000 shares at an average $23.24 ($348,665)
  14. 4 Open-market sale Chief Operating Officer sold 12,626 shares at an average $23.62 ($298,237)
  15. 4 Open-market sale Chief Medical Officer sold 2,595 shares at $19.03 ($49,383)
  16. 4 Open-market sale Chief Technology Officer sold 2,520 shares at $19.03 ($47,956)
  17. 4 Open-market sale Chief Medical Officer sold 1,272 shares at $16.30 ($20,734)
  18. 4 Open-market sale Chief Technology Officer sold 1,585 shares at $16.30 ($25,836)
  19. 4 Derivatives Options or other derivatives
  20. 4 Open-market sale Chief Technology Officer sold 2,805 shares at $18.15 ($50,911)

Page 3 of 18 · 360 filings